Evidence map›Paper›PMID 19559119›Full record

ArticleVaccine2009

In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes.

Leonard Moise, Julie A McMurry, Soren Buus, Sharon Frey, William D Martin, Anne S De Groot

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 66 citations in OpenAlex.

  1. Bioinformatics and biology insights · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. A subunit vaccine against pneumonia: targeting SNetwork modeling and analysis in health informatics and bioinformatics · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.International journal of biological macromolecules · 2020
    Article
  12. Human vaccines & immunotherapeutics · 2020
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Leonard MoiseEpiVax, Inc., Providence, RI, USA.
Julie A McMurry
Soren Buus
Sharon Frey
William D Martin
Anne S De Groot
Providence College · USEpiVax (United States) · USSaint Louis University · USUniversity of Copenhagen · DK

Funding

TRIAD Scientific Core: TRIAD ToolkitU19AI082642 · NIAID · UNIVERSITY OF RHODE ISLAND · PI PAQUETTE, GREGORY · 2009 to 2013
$13.0M
Novel Smallpox Vaccine Derived from VV/VAR ImmunomeR43AI058376 · NIAID · EPIVAX, INC. · PI DEGROOT, ANNE SEARLS · 2005 to 2006
$1.0M
NIAID NIH HHS R43 AI058376NIAID NIH HHS R43AI058376NIAID NIH HHS U19 AI082642
6 · The paper itself

Abstract

Epitopes shared by the vaccinia and variola viruses underlie the protective effect of vaccinia immunization against variola infection. We set out to identify a subset of cross-reactive epitopes using bioinformatics and immunological methods. Putative T-cell epitopes were computationally predicted from highly conserved open reading frames from seven complete vaccinia and variola genomes using EpiMatrix. Over 100 epitopes bearing low human sequence homology were selected and assessed in HLA binding assays and in T-cell antigenicity assays using PBMCs isolated from Dryvax-immunized subjects. This experimental validation of computational predictions illustrates the potential for immunoinformatics methods to identify candidate immunogens for a new, safer smallpox vaccine.

Indexed as

AdultComputational BiologyCross ReactionsEpitope MappingEpitopes, T-LymphocyteGenes, MHC Class IGenes, MHC Class IIGenome, ViralHumansOpen Reading FramesSmallpox VaccineT-LymphocytesVaccinia virusVariola virusYoung AdultDryVax vaccineEpitopes, T-LymphocyteSmallpox Vaccine

Identifiers

PMID19559119
PMCPMC2838212
OpenAlexW2015855391

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.